# A Study Of CP-195543 And Celecoxib Dual Therapy In Subjects With Rheumatoid Arthritis

> **NCT00424294** · PHASE2 · TERMINATED · sponsor: **Pfizer** · enrollment: 70 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** CP-195,543
- **DRUG:** celecoxib
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT00424294
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-06
- **Primary completion:** 2007-12
- **Final completion:** 2008-02
- **Target enrollment:** 70 (ACTUAL)
- **Why stopped:** See Detailed Description field
- **Last updated:** 2014-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00424294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00424294, "A Study Of CP-195543 And Celecoxib Dual Therapy In Subjects With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00424294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*